Disease Burden of Patients With Osteoarthritis: Results of a Cross‐Sectional Survey Linked to Claims Data

Johanna Callhoff,Katinka Albrecht,Imke Redeker,Toni Lange,Jens Goronzy,Klaus‐Peter Günther,Angela Zink,Jochen Schmitt,Joachim Saam,Anne Postler

DOI: https://doi.org/10.1002/acr.24058

2020-01-29

Abstract:ObjectiveOsteoarthritis (OA) is a major reason for chronic pain, stiffness and functional limitation. The aim was to analyze factors associated with the burden of OA, taking the pattern of joint involvement into account. MethodsFrom a random sample of 8,995 persons with OA (ICD‐10 codes M15 [polyarticular], M16 [hip] or M17 [knee]) from a German statutory health insurance, 3,564 persons completed a survey including the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Persons with knee, hip, concomitant knee and hip or polyarticular manifestation were compared concerning pain, stiffness, function, and impact on work/personal life. Data were linked to dispensation records. The association of age, gender, BMI, symptom duration and WHO‐5 with the WOMAC was assessed in multiple linear regression models. ResultsPersons with knee (n=1,448), hip (n=959), knee and hip (n=399) or polyarthritic (n=758) OA were included. Concomitant knee and hip OA was accompanied by the highest WOMAC values (mean 44), frequent impairment of personal life (75%) and the highest use of analgesics (52% NSAIDs, 22% opioids and 37% others). In the regression analyses, BMI per 5 units and WHO‐5 per 10% worsening were associated with an increase in WOMAC values of 4‐5 points, irrespective of the joint manifestations. ConclusionDisease burden is high in persons with concomitant knee and hip OA, going along with frequent prescription of analgesics. Involvement of several joints, BMI and depressive symptoms need to be considered when using the WOMAC as an outcome instrument.This article is protected by copyright. All rights reserved.

rheumatology